Management

Eric A. Adams, MIBS

Chief Executive Officer & President

Eric A. Adams was appointed Chief Executive Officer, President and Director of InMed Pharmaceuticals, Inc. in June 2016. During his tenure at InMed, he has reconstituted the Board of Directors and the Executive management team and has raised more than $35M in

Learn More

Jeff Charpentier, CPA, CA

Chief Financial Officer

Mr. Charpentier is a veteran of the biopharmaceutical industry with 26 years of experience. Mr. Charpentier has held a series of senior financial roles at several public and private companies in the pharmaceutical and technology sectors. Mr. Charpentier has

Learn More

Josh Blacher, MBA

Chief Business Officer

Mr. Blacher brings two decades of leadership experience in senior positions within the US healthcare and capital markets sectors, focusing primarily on strategic finance, business development, and managing relations with the investment community.

Learn More

Alexandra D.J. Mancini, MSc

Senior Vice President, Clinical & Regulatory Affairs

Ms. Mancini has over 30 years of global biopharmaceutical R&D experience, overseeing a wide range of drug development activities, with a particular emphasis on clinical development and regulatory affairs. She has been an executive with numerous biotech

Learn More

Eric C. Hsu, PhD

Senior Vice President, Pre-Clinical Research & Development

Dr. Hsu joined InMed with over 18 years of scientific leadership experience in the field of gene therapy. Prior to joining InMed, he held various positions within enGene Inc., including V.P. of Research and V.P. of Scientific Affair and

Learn More

Michael Woudenberg, P.Eng.

Vice President, Chemistry, Manufacturing & Controls

Mr. Woudenberg joined InMed with over 20 years of engineering, leadership and GMP manufacturing and scale up experience with regards to the development, technology transfer and commercialization of active pharmaceutical ingredients (APIs) and drug products. He

Learn More